| The findings, the study's
author says, turn the current model about ghrelin on its head and point
to a novel stomach enzyme (GOAT) responsible for the ghrelin activation
process that could be targeted in future treatments for metabolic
diseases.
The laboratory study, led by Matthias Tschöp, MD, UC
associate professor of psychiatry and internal medicine, is published
online ahead of print Friday, June 5, 2009, in the journal Nature
Medicine.
Ghrelin is a hormone that was believed to accumulate
during periods of fasting and is found in the body in high
concentrations just before meals. It is dubbed the "hunger hormone"
because it has been shown that administration of pharmacological doses
acts in the brain to stimulate hunger and increase food intake in animal
models and humans.
The ghrelin hormone is unique in that it requires
acylation (the addition of a fatty acid) by a specific enzyme (ghrelin
O-acyl transferase, or GOAT) for activation. Originally it was assumed
that the fatty acids attached to ghrelin by GOAT were produced by the
body during fasting.
The new data by Tschöp and his team suggests that the
fatty acids needed for ghrelin activation actually come directly from
ingested dietary fats. In a departure from an earlier model that was
upheld for nearly a decade, Tschöp says, it appears that the ghrelin
system is a lipid sensor in the stomach that informs the brain when
calories are available—giving the green light to other calorie-consuming
processes such as growing.
Tschöp and his team used mouse models to test the
effects of over expressing the GOAT enzyme, or "knocking it out." They
found that, when exposed to a lipid-rich diet, mice without GOAT
accumulated less fat than normal mice, while those with over-expressed
GOAT accumulated more fat mass than normal mice.
"When exposed to certain fatty foods, mice with more
GOAT gain more fat," says Tschöp. "Mice without GOAT gain less fat since
their brain does not receive the 'fats are here, store them' signal."
Tschöp says that although his study can't be
immediately extrapolated to humans, recent human studies at the
University of Virginia measured (separately) active and inactive ghrelin
concentrations. Those studies showed that during fasting, active ghrelin
levels were flat, but during the presence of fat from foods, ghrelin
levels peaked with meals as previously described. Tschöp says these
human studies support the new model for ghrelin.
"Our GOAT studies in mice offer an explanation of what
could have been happening during the longer fasting periods in these
human studies," Tschöp adds. "Without dietary fats, ghrelin peaks remain
inactive and don't affect storage of fat.
"We are particularly interested in how ghrelin may be
involved in the rapid benefits of gastric bypass surgery," says Tschöp.
"This powerful obesity therapy frequently reduces appetite and improves
metabolism before substantial weight loss occurs. Intriguingly, this
procedure causes food to bypass the stomach and gut sections that
contain GOAT/ghrelin cells, which, based on this newly described model,
would prevent ghrelin activation."
|